Imprimis Pharma (IMMY) Misses Q2 EPS by 7c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. WCN
7. SPOT
8. SPY
9. FIX
10. TSCO

Go back to Imprimis Pharma (IMMY) Misses Q2 EPS by 7c

Imprimis Pharmaceuticals Announces Second Quarter 2015 Financial Results and Provides Business Update

August 12, 2015 4:05 PM EDT

SAN DIEGO, Aug. 12, 2015 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), a pharmaceutical company focused on the development and commercialization of proprietary compounded drug formulations, today announced its financial results for the second quarter ended June 30, 2015.  Management will discuss the financial results and recent business updates on a conference call this afternoon at 4:30 p.m. EDT.

Key Second Quarter 2015 Accomplishments and Recent Developments

Financial Highlights

Total revenues reported for the second quarter 2015 were $2.0 million,... More